Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Jackson-Perry D, Amstutz A(2025) Should we be paying more attention to HIV and adult ADHD? Lancet HIV(in press) DOI 10.1016/S2352-3018(25)00235-8, PubMed 40850324
Sachs-Strømmen K, Thorsteinsdottir H, Sakhi AK, Thomsen C, Lie A, Bjerre A, Lyche JL(2025) Urinary levels and estimated daily intake of phthalates and phenols in kidney transplanted Norwegian children Sci Total Environ, 998, 180251(in press) DOI 10.1016/j.scitotenv.2025.180251, PubMed 40845701
Michelsen TM, Sajjad MU, Haugen G, Moore L, Julian CG, Sørbye IK, Henriksen T(2025) Maternal body mass index is related to fetal uptake of glucose and oxygen via fetal insulin resistance rather than fetal glucose levels Philos Trans R Soc Lond B Biol Sci, 380(1933), 20240178 DOI 10.1098/rstb.2024.0178, PubMed 40836801